Optomed - Terveysteknologiayhtiö

AEYE Health tiedotteli uudesta jakelijasopimuksesta.

Toku Eyes tiedotti uudesta yhteistyöstä todella potentiaalisen kumppanin kanssa, jolle sopii nimenomaan kannettava kamera. Tässä on Optomedille erinomaisen mehevä uusi keissi, jahka Tokun kanssa saadaan FDA-rumba juoksutettua läpi.


SANTA MONICA, Calif., July 7, 2025 /PRNewswire/ – Lifeforce, the world’s largest longevity medicine platform, and Toku, a health technology company using AI to translate a single retinal image into real-time biological age and cardiovascular risk scores, have announced a nationwide partnership. The collaboration will turn thousands of routine eye exams each week into powerful opportunities for early health insights and proactive intervention.

The partnership integrates Toku’s BioAge™ wellness product with its forthcoming CLAiR™ technology—a recipient of the prestigious FDA Breakthrough Device designation, which is awarded to technologies that may offer more effective diagnosis or treatment of life-threatening or irreversibly debilitating conditions. CLAiR is currently on an accelerated development path, with anticipated FDA approval in 2026, and aims to transform non-invasive cardiovascular risk assessment using retinal imaging and AI.

43 tykkäystä